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Asparagine synthetase (ASNS) is a housekeeping gene responsible
for the biosynthesis of L-asparagine (ASN). The gene is expressed
constitutively in most mammalian cells and regulates its level of
activity in response to the concentration of ASN in the plasma or
medium, and the extent of tRNA aminoacylation (Andrulis et al,
1979). In contrast to normal cells, the cells of a number of animal
malignancies, especially lymphoid, are ASN auxotrophs that fail
to express ASNS. In these, deprivation of exogenous ASN by 
L-asparaginase (Asnase) induces cell death (Broome, 1963; Boyse
et al, 1967). This forms the basis for the clinical use of the enzyme
as a therapeutic agent for acute lymphocytic leukaemia (Tallal
et al, 1970). In the prototypic mouse system, 6C3HED, an Asnase-
sensitive lymphoma cell line originating in the C3H strain (here
designated 6C3HED-Ade), lacked ASNS activity, as did various
similar lymphoma and other cell lines (Patterson and Orr, 1967;
Broome, 1968; Horowitz et al, 1968). However, ASNS activity
was present in Asnase-resistant variants of 6C3HED (6C3HED-
Ind), which grew out during culture in the absence of ASN or after
treatment with subcurative doses of enzyme in vivo. The mecha-
nism responsible for the lack of ASNS in the Asnase-sensitive
lymphoma cells as opposed to the Asnase-resistant variants has
not been studied in recent years, but in addition to theoretical
interest, it may be of clinical significance in understanding the
responsiveness of acute lymphocytic leukemia to enzyme treat-
ment both initially and during relapse. 
The regulation of ASNS mRNA by amino acid concentration
has transcriptional and post-transcriptional components involving
both cis- and trans-acting factors (Guerrini et al, 1993). Within the
human ASNS promoter, the amino acid response element is
important for both basal activity and regulation of ASNS expres-
sion under amino acid starvation. Evidence that indirectly
suggested that methylation might play a role in regulating ASNS
gene expression came from studies made in conjunction with
cloning the human gene. It was shown that transfection with plas-
mids containing human ASNS cDNA into cells of the ASN-
dependent Jensen rat sarcoma was capable of conferring protrophy
(Andrulis et al, 1987). However, several transfectants with
numerous copies of the cDNA exhibited only basal levels of
enzyme activity. Treatment of these transfectant cell lines with 5-
azacytidine, an inhibitor of DNA methylation, greatly increased
the expression of ASNS mRNA, protein and enzyme activity. This
was consistent with the finding that 5-azacytidine caused a marked
increase in the number of ASN protrophs in cultures of Jensen
cells (Sugiyama et al, 1983). However, no full and direct exam-
ination of the methylation status of ASNS has been made until
now. Our present experiments have characterized the CpG
island in the promoter of the mouse ASNS gene and correlated
its hypermethylation with inactivation of gene expression in
ASN-dependent lymphoma cells. To our surprise, we found that
partial methylation in CpG islands of ASNS also occurred in
prototrophs from 6C3HED and in other cell lines that are intrinsi-
cally ASN independent. So too, normal splenic cells showed
partial methylation, the frequency of which was age dependent.
These observations may exemplify a process whose relation to
oncogenesis is the subject of much interest (Issa, 1999). 
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MATERIALS AND METHODS 
Cell lines and cell culture 
6C3HED cells were obtained frozen from DCTDC Tumor
Repository (National Cancer Institute, Frederick, MD, USA) and
after implantation in C3H/He/Jax mice, tumour was inoculated
into Dulbecco’s modified Eagles medium (DMEM) with 10% fetal
calf serum and ASN supplementation (5 mg/100 ml) and main-
tained in this medium. ASN-independent 6C3HED cell lines (vari-
ants) were obtained from cultures as described (Broome, 1963).
These and cells of L1210 and EL4 (American Type Culture
Collection) were cultured in the absence of exogenous ASN over
periods of 6 months or more before harvesting for further studies. 
RNA preparation and Northern blot analysis 
Total cellular RNA was isolated from cultured cells or fresh frozen
tissue by Trizol reagent (GIBCO/BRL). Ten µ g of total RNA was
electrophoresed in 1% agarose gels in the presence of formalde-
hyde, and blotted onto Nytran membranes by standard capillary
transfer and UV cross-linking. All the blots were stained with
methylene blue to demonstrate equivalent loading of RNA and to
mark the migration of 18S rRNA, 28S rRNA and RNA molecular
weight ladders (Bethesda Research Laboratories). A mouse ASNS
cDNA probe was prepared by isolating a 1.5 kb fragment from an
EcoRI restriction digest of a mouse ASNS total length cDNA
clone (Goodwin et al, unpublished data), which was then labelled
with  32P-dCTP using a random primer. After hybridization with
this probe, the blots were re-hybridized to the DNA probe of 
β -actin as internal controls. 
mRNA expression analysis using RT-PCR 
RNA was isolated from 6C3HED-Ade and Ind cells as described
and from 6C3HED-Ade cells cultured for 24 hours in ASN-
containing medium with added 5-aza-2′ -deoxycytidine. Com-
plementary DNA was synthesized using reverse transcriptase E
(Gibco/BRL) following the manufacturer's instructions. PCR
reactions were performed in volumes of 50 µ l consisting of
200 mmol/l of dNTPs, 10 pmol primers, 2.5 mmol/l of MgC12,
and 2.5 units of AmpliTaq Gold DNA polymerase (Applied
Biosystems) with 4 µ l of cDNA in the manufacturer’s buffer
(Applied Biosystems). The primers for amplification of ASNS
cDNA were 5′ CTCTACCTTTGATGTT 3′ and 5′ GTATTGAAG-
GGAAACTTC 3′ , derived from the cDNA sequence obtained by
Goodwin et al (Unpublished data) (Gen Bank Accession
#U38940). Mouse GAPDH message was similarly treated as a
quantitative control for cellular mRNA. Reactions were carried
out in a DNA Thermal Cycler (Perkin-Elmer, Gene Amp 2400)
under the following conditions: 94˚C for 10 min, then 94˚C/30 s,
55˚C/30 s, 72˚C/1 min for 35 cycles followed by 7 min at 72˚C.
Products were analyzed on a 10% acrylamide gel and stained by
ethidium bromide visualized under UV light. 
Isolation and characterization of mouse ASNS
promoter 
From the cDNA sequence of Goodwin et al (Unpublished data) we
expanded the 5′ promoter region by walking upstream of exon
one, using Genome Walker™ kits (Clontech, Palo Alto, CA, USA)
and a specific primer designed from 5′ end of murine ASNS exon
one. PCR products from the libraries produced were cloned into
the pGEM®-T Easy vector (Promega, Madison WI, USA) and
sequenced using an applied Biosystems PRISM 373 DNA auto-
matic sequencer and a Big Dye terminator cycle sequencing kit.
Sequence homology analysis was performed by Blast Search
(www4.ncbi.nlm.nih.gov) and CpG island analysis using a
programme provided by NIH, Japan (http://www.nih.go.jp/~
mhirata/cpg-Per.html). 
DNA isolation and methylation analysis 
Genomic DNA was isolated by the standard method of proteinase
K digestion and phenol – chloroform extraction. A quantity of 2
µ g of genomic DNA was treated with sodium bisulfite to convert
all unmethylated cytosines to uracil (Frohmer et al, 1992; Herman
et al, 1996) using the protocol from ‘Resource on DNA
Methylation in Aging and Cancer Web site’: (http://www.
mdanderson.org/leukemia/methylation). After conversion, DNA
methylation analysis was performed by both methylation-specific
PCR and bisulfite genomic sequencing. For the latter, primer
design and PCR conditions followed the above protocol.
Primer set 1 consisted of 5′ ’TGTTGATGGGATATTGGATTG 3′
and 5′ ’TCATATAACTAAAACCCAACCC 3′ and primer set
2 consisted of 5′ ATAGAAGTAGAATATTTTTTGG3′ , 5′
CCAAAACCAAAAAAAATAAAAC3′ . The PCR product was
cloned into plasmid PCR 2.1 by the original TA cloning kit
(Invitrogen, Carlsbad, CA, USA) and clones from each PCR
product were sequenced. 
RESULTS 
ASNS gene expression in 6C3HED cells 
In accordance with the lack of ASNS activity, no mRNA of the
gene was found in 6C3HED-Ade cells. By contrast, a 2 kb
message was expressed in 6C3HED-Ind tumour cells. Messenger
RNA of similar size is expressed in normal mouse tissues, particu-
larly in the brain (Figure 1). Under some conditions, tissue
12 34 5
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Figure 1 Northern blot analysis of ASNS in mouse tissues and lymphoma
cells. All panels show 10 µ g of RNA electrophoresed in 1% agarose gels,
blotted, and hybridized with the mouse ASNS cDNA probe (upper panel).
The blots were stripped for sequential hybridization with β -actin probe (lower
panel). Upper panel: A 2 kb ASNS mRNA was detected in mouse brain (lane
1), spleen (lane 2), kidney (lane 3) and 6C3HED cells in lane 4 (ASN-
independent cell line in DMEM with ASN supplementation) after overnight
exposure. However, no ASNS mRNA was present in lane 5 (ASN-dependent
6C3HED cells with ASN supplementation in DMEM), even after 1 week’s
exposure. The lower panel shows the same blot hybridized with β -actin
probe 
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cultured cells can also express a 4 kb message, with the additional
length being in the 3′ region (data not shown). 
To determine whether gene silencing might be due to promoter
methylation, we cultured asparagine-dependent lymphoma cells
with 5-aza-2′ deoxycytidine, and tested for the expression of the
ASNS message by RT-PCR. As shown in Figure 2, distinct expres-
sion was induced in 24 h. However, the agent proved toxic and no
permanently ASN-independent variants were obtained. 
Next we examined directly the methylation status of the
promoting region of the gene. 
Isolation and characterization of the promoter of
mouse ASNS gene 
From 5 Genome Walker libraries, we obtained PCR products from
4. On sequencing, 1 clone showed a high degree of homology with
hamster and human ASNS 5′ regions (Greco et al, 1989; Andrulis
et al, 1989). The mouse sequence from +1 to –1052 includes the
entire untranslated exon 1 and a further 953 bp upstream
(GenBank Accession # Bank It 333658 AF 262321). As shown in
Figure 3A, starting from –252 to –102, it shares over 80%
homology with 5′ regions of hamster ASNS. Interestingly, the
short open reading frame (ORF), which precedes the transcription
start site, has very high homology with both hamster and human
ASNS genes at the DNA and deduced amino acid sequence levels.
In the 5′ region, the mouse ASNS gene shares over 70% homology
with the human only at this site. Of 14 amino acids of the mouse
short ORF, 11 are identical to the human and 12 are identical to
hamster (Figure 3A). Strikingly, Guerrini et al (1993) found that
mutations in this region not only decreased the basal promoter
activity but also abolished amino acid regulation. This highly
conserved region is therefore likely to play a major role in the
control of ASNS expression. As in both the human and hamster,
no TATA box or CCAAT sequences were found in the 5′ region,
which is consistent with findings in many housekeeping genes.
However, the sequence from –284 to the translation start site is
very G + C rich and contains numerous CpG dinucleotides.
Sequence analysis confirmed a CpG island in this region (Figure
3B), which therefore had the potential for silencing expression of
the ASNS gene by methylation. 
Methylation profile of CpG islands of mouse ASNS
gene in lymphoma cell lines and normal mouse cells 
To correlate methylation with silencing of ASNS expression in
6C3HED-ADE, we first performed methylation-specific PCR on
bisulfite-modified DNA. We found that the DNA of these cells
could be amplified by the primer for methylation but not by the
primer for unmethylation. But to our surprise, DNA from
6C3HED-Ind was amplified by both types of primer. To analyze
the methylation patterns more precisely throughout the whole CpG
island of the promoter, we designed 2 sets of PCR sequencing
primers for bisulfite-treated DNA. Primer set 1 encompassed –325
to –168 and primer set 2 covered –248 to –37, which together
included a total of 22 CpG sites spanning 288 bp. Primer set 1
covered 2 CpG sites upstream, which were not covered by set 2,
while the latter conversely included 9 more CpG sites downstream
than set 1. Direct PCR product sequencing was performed on
DNA from 63HED-Ade, 6C3HED-Ind, and 2 intrinsically ASN-
independent lymphoma cell lines: L1210 and EL4. Virtually
complete hypermethylation in CpG islands with partial methyla-
tion at only a few inconstant CpG sites was found in 6C3HED-
Ade but unclear (heterogeneous) sequencing tracings were derived
from the other samples. To quantitate the precise proportion of
genes with methylated CpG islands, we then cloned the PCR prod-
ucts of bisulfite-treated DNA from the mouse cell lines and
sequenced colonies from each PCR-derived clone. We found that
all 16 clones from 6C3HED-Ade showed a pattern of virtually
complete methylation: 4 clones were methylated in all 22 CpG
sites, the remainder had a few (1–4) randomly distributed
unmethylated sites. However, surprisingly, 38% (12 out of 32) of
clones from 6C3HED-Ind and 44% (4 out of 9) of clones from
L1210 were similarly methylated. EL4 showed methylated and
unmethylated clones (Table 1). The results demonstrated that the
inhibition of ASNS gene expression was only observed with
complete hypermethylation of CpG islands. The detailed methyla-
tion profile in 19–20 consecutive CpG sites using primer set 2 in
6C3HED cells is shown in Figures 4 A & B. Next we proceeded to
examine the status of the gene in normal cells. DNA from wean-
ling mouse spleens showed no methylation of the CpG island.
However, in 17-week-old C57 and 18-week-old C3H mice,
respectively, 15% (4 out of 27) and 45% (5 out of 11) of the clones
were methylated. In an old C3H mouse (48 weeks of age), a high
proportion (44%) were methylated. Methylation profiles are
shown in Figure 4C&D. The frequency of methylation varied
between organs. In the liver, methylation was only seen in one 48-
week-old animal, with the very low frequency of 1 clone in 11
(Table 1). 
DISCUSSION 
In accordance with much other work (Li, 1999; Ng et al, 1999;
Wade et al, 1999) the hypermethylation of the CpGs in the
m-AS
m-GAPDH
12 3 4 5 6 7
Figure 2 Effect of 5-AZA-2 deoxycytidine on the transcription of mouse
asparagine synthetase in 6C3HED cells. RT-PCR was performed with RNA
from 6C3HED-Ade cells (lane 4, negative control), 6C3HED-Ind cells (lane 5,
positive control) and 6C3HED-Ade cells cultured with 5 µ M of 5-aza-2′
deoxytytidine for 24 h (lane 6) and 10 µ M (lane 7). 1 kb molecular marker is
shown (lane 1), H2O control (lane 2), and RNA without reverse transcriptase
(lane 3) 
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promoter of ASNS is in all probability the primary cause for its
failure to be expressed in ASN-dependent 6C3HED cells,
although other secondary changes consequent on methylation are
probably involved. In these cells there are two alleles (demon-
strated by FISH, data not shown) and hence both must be methy-
lated. On the other hand, most ASN-independent cells probably
contain 1 methylated and 1 unmethylated allele. The alternative
explanation of a mixed cell population containing either methy-
lated or unmethylated genes is most unlikely. ASN-independent
variant lines were grown for at least 50 transfer generations in the
absence of exogenous ASN, a condition which would clearly
select against dependent cells. Furthermore even after a long
period of conditioning (48 hours) by independent cells at high
density (5 × 106/ml), the medium contains only low levels of ASN
(< 10 µ M), considerably less than the minimum concentration of
100 µ M required to support the growth of dependent cells
(Broome, 1963, 1968). Interestingly, we show that in normal
mouse spleen, an age-related change appears to be associated with
de novo CpG island methylation in the ASNS gene. Furthermore,
this methylation is tissue specific. Methylation is high in the
spleen but very low in the liver. 
In the case of normal spleen cells, since older animals show
approximately half the gene copies to be methylated, each cells
may contain both a methylated and an unmethylated allele.
Alternatively, the degree of methylation may depend on the
lymphocytic cell type, with 1 (or more) being unmethylated and
the other(s) methylated. The latter would be expected to be Asnase
sensitive. Since Asnase is immunosupressive in the mouse (Maral
et al, 1979), this possibility merits further study. 
The observations in this paper can be considered from a number
of more fundamental aspects. First, is the age relationship of
methylation in the ASNS gene. It should be pointed out that the
differences between weanlings and adults now demonstrated need
to be extended to show that the progression of methylation is
continuous and to exclude it being solely due to adolescent
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Figure 3 (A) Partial sequence of promoter region of ASNS and
demonstration of homology to hamster and human genes. (B) Identification of
CpG island 
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Figure 4 Methylation profiles of consecutive CpGs in various cell types. Sequencing was performed on products from clones of bisulfite-treated DNA, using
primer set 2 (see text).   Methylated ❍ Unmethylated. Clones are numbered vertically 
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maturation. If this is so, then the methylation falls into a pattern
that has been the subject of much interest in various systems
(Reviewed by Issa, 1999, 2000). Ageing produces paradoxical
effects on methylation in normal tissues. Hypomethylation,
primarily of repeated sequences of Alu and satellite DNA is a
well-recognized occurrence (Mays-Hoops et al, 1986). By
contrast, hypermethylation of CpG islands associated with
promoting regions, which in general is linked to silencing of tran-
scription, has been shown to be age associated in an increasing
number of identified genes (at least 8) (Issa, 2000). The most
comprehensive studies of this phenomenon have been in epithelial
cells of the large intestine, prostate and breast, particularly in rela-
tion to tumour formation. Until the present study a comparable
occurrence in haemopoietic cells has not been reported. 
Secondly, genes that have shown age-specific methylation do
not necessarily have a gene product that can be associated with
cellular growth control, for instance, the muscle-specific MYODI
(Rideout et al, 1994). ASNS would appear to be in this category,
since there is no prima facie reason that lack of expression of a
housekeeping gene would confer a growth advantage. Indeed, the
occurrence of methylation may depend on local factors within the
chromatin, which are irrespective of function and perhaps relate to
changes in methylase activity (Herman and Baylin, 2000). Various
mechanisms have been proposed for the spread of methylation
from 1 allele to its homolog (Flavel, 1994) but their relevance to
the biallelic methylation of ASNS in lymphomas is unknown. 
The question may be raised of whether lymphoid cells that show
ASNS methylation have an increased propensity to neoplastic
change. Both might occur as part of a de novo change in methyla-
tion phenotype, the ‘methylome’ (Feinberg, 2001), which amongst
other effects can cause the silencing of one or more tumour
suppressor genes (Jones and Gonzalgo, 1997; Eng et al, 2000;
Costello et al, 2000). 
Finally, in whatever way these speculative, but experimentally
testable issues may be resolved, the evidence for ASNS inactiva-
tion in lymphoid tumours provides a specific example of how a
defined epigenetic change can have therapeutic potential. 
ACKNOWLEDGEMENTS 
We thank Craig Gawel and Dorothy Guzowski for expert assis-
tance in sequencing and primer synthesis. 
REFERENCES 
Andrulis IL, Chen J and Ray PN (1987) Isolation of human cDNAs for asparagine
synthetase and expression in Jensen rat sarcoma cells. Mol Cell Biol 7:
2435–2443 
Andrulis IL, Hatfield WG and Arfin SM (1979) Asparaginyl t-RNA aminoacylation
levels in asparagine synthetase expression in cultured chinese hamster ovary
cells. J Biol Chem 254: 10629–10633 
Andrulis IL, Shotwell M, Evans-Blockler S, Zalkin H, Siminovitch I and Ray PN
(1989) Fine structure analysis of the chinese hamster gene encoding asparagine
synthetase. Gene 80: 75–80 
Boyse EA, Old LJ, Campbell HA and Mashburn LT (1967) Suppression of murine
tumors by L-asparaginase. J Exp Med 125: 17–31 
Broome JD (1963) Evidence that the L-asparaginase of guinea pig serum is
responsible for its antilymphoma effect. J Exp Med 118: 99–148 
Broome JD (1968) Studies on the mechanism of tumor inhibition by L-asparaginase.
J Exp Med 127: 1055–1072 
Costello JF, Fruhwald MC, Smiraglia DJ, Rush LJ, Robertson GP, Gao X, Wright
FA, Feramisco JD, Peltomaki P, Lang JC, Schuller DE, Yu L, Bloomfield CD,
Caligiuri MA, Yates A, Nishikawa R, Huang H.-JS, Petrelli NJ, Zhang X,
O’Dorisio MS, Held WA, Cavanee WK and Plass C. Aberrant CpG-island
methylation has non-random and tumor-type specific patterns Nat Genet 25:
132–138 
Eng CE, Herman JG and Baylin SB (2000) A bird’s eye view of global methylation.
Nat Genet 25: 101–102 
Feinberg AP (2001) Methylation meets genomics. Nat Genet 27: 9–10 
Frohmer M, Mc Donald LE, Miller DS, Collis CM, Watt F, Grigg GW, Molloy PL
and Paul CL (1992) A genomic sequencing protocol that yields a positive
display of 5-methylcytosine residues in individual DNA strands. Proc Natl
Acad Sci USA 89: 1827–1831 
Greco A, Gong SS, Ittmann M and Basilico C (1989) Organization and expression of
the cell cycle gene, ts 11, that encodes asparagine synthetase. Mol Cell Biol 9:
2350–2359 
Guerrini L, Gong SS, Mangasarian K and Basilico C (1993) Cis-and transacting
elements involved in amino acid regulation of asparagine synthetase gene
expression. Mol Cell Biol 13: 3202–3212 
Herman JG and Baylin SP (2000) Promoter-region hypermethylation and gene
silencing in human cancer. In: Jones PA and Vogt PK (eds), Current Topics in
Microbiology & Immunology 249: pp 35–54. Springer-Verlag: Berlin 
Table 1 Methylation of ASNS in DNA from mouse lymphoma and normal cells 
DNA source No. of clones  No. of methylated  Methylation  
sequenced clones proportion (%)
Lymphoma 6C3HED-Ade 16 16 100 
cell line 6C3HED-Ind 32 12 38 
L1210 9 4 44 
EL4 4 2 50 
38 00  
39 00  
39 00  
Spleen 3 8 0 0 
(age – weeks) 17* 27 4 15 
18 11 5 45 
48 9 4 44 
Liver 17* 9 0 0 
(age – weeks) 18 12 0 0 
48 11 1 9 
DNA was obtained from C3H/He, C3D2 F1/Jax or C57 BL/6J (*) mice. The number of methylated clones is
the sum of those examined using primer set 1 or primer set 2. Detailed methylation patterns with primer
set 2 are shown in Figure 4. 
BJOC 01-2000 930-935  10/9/01  1:57 pm  Page 934Methylation of asparagine synthetase promoter in lymphomas 935
British Journal of Cancer (2001) 85(6), 930–935 © 2001 Cancer Research Campaign
Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB (1996) Methylation
specific PCR: a novel PCR assay for methylation status of CpG islands. Proc
Natl Acad Sci USA 93: 9821–9826 
Issa JP (1999) Aging, DNA methylation and cancer. Crit Rev Oncol Hematol 30:
31–43 
Issa JP (2000) CpG-Island methylation in aging and cancer. In: Jones PA and Vogt
PK (eds), Current Topic in Microbiology & Immunology 249: pp 101–118.
Springer-Verlag: Berlin 
Jones PA and Gonzalgo ML (1997) Altered DNA methylation and genome
instability: A new pathway to cancer Proc Natl Acad Sci USA 94: 
2103–2105 
Li E (1999) The mojo of methylation. Nat Genet 23: 5–6 
Maral R, Guyonnet JC, Julol L, de Ratuld Y and Werner GH (1970) Studies on the
immunosuppressive activities of L-asparaginase. Recent Results Cancer Res
33: 160–169 
Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H,
Tempst P, Reinberg D and Bird A (1999) MBD2 is a transcriptional 
repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet 23:
58–61 
Patterson MK and Orr G (1967) L-asparagine biosynthesis by nutritional variants of
the Jensen sarcoma. Biochem Biophys Res Commun 26: 228–233 
Sugyiana RH, Arfin SM and Harris M (1983) Properties of asparagine synthetase 
in asparagine-independent variants of Jensen rat sarcoma cells induced by 
5-azacytidine. Mol Cell Biol 3: 1937–1942 
Tallal L, Tan C, Oettgen H, Wollner N, McCarthy M, Helson L, Burchenal J,
Karnofsky D and Murphy ML (1970) E. Coli L-asparaginase in the treatment
of leukemia and solid tumors in 131 children. Cancer 25: 306–320 
Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F and Wolff AP (1999) Mi-2
complex couples DNA methylation to chromatin remodelling and histone
deacetylation. Nat Genet 23: 62–66
BJOC 01-2000 930-935  10/9/01  1:57 pm  Page 935